Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Bausch Health Companies Inc.
Next earnings Jul 28, 2026 · consensus $1.08 EPS, $2.70B rev
Last earnings -1.4% on 2026-04-29
Revenue grew 6.7% YoY; but thin net margin (1.5%).
Sources: SEC EDGAR (CIK 0000885590, latest 10-Q filed 2026-04-30) · EODHD · as of 6/22/2026, 7:13:49 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Middling fundamentals offset by an attractive price (~219% below fair value) — worth a look on the value angle.
Bausch Health Companies Inc. shows $10.3B in FY2025 revenue (+6.7% YoY), a 1.5% net margin, and -28.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $8.43B | $8.12B | $8.76B | $9.63B | $10.3B |
| Gross profit | — | — | — | — | — |
| Operating income | $450M | $454M | $963M | $1.55B | $1.81B |
| Net income | -$948M | -$225M | -$592M | -$46.0M | $157M |
| Diluted EPS | -$2.64 | -$0.62 | -$1.62 | -$0.13 | $0.42 |
| Net margin | -11.2% | -2.8% | -6.8% | -0.5% | 1.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2026-05-22 | WECHSLER AMY B Director | Award | 45.9K | |
| 2026-05-22 | ROBERTS EIRY Director | Award | 45.9K | |
| 2026-05-22 | POWER ROBERT N Director | Award | 45.9K | |
| 2026-05-22 | Paulson John Director | Award | 45.9K | |
| 2026-05-22 | LEUNG SANDRA Director | Award | 45.9K | |
| 2026-05-22 | Lee Frank D. Director | Award | 45.9K | |
| 2026-05-22 | KAVANAGH SARAH B Director | Award | 45.9K | |
| 2026-05-22 | GOETTLER MICHAEL Director | Award | 45.9K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.